CVS Health hiked its 2025 forecast above Wall Street’s expectations after improving Medicare benefits contributed to a better ...

Eli Lilly’s stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound.

CVS Health shares powered 9% higher before the bell Thursday after the pharmacy and healthcare giant's first-quarter results ...

Eli Lilly and Company's stock dropped 11% after CVS's Zepbound exclusion, but analysts see a mispricing opportunity. Click ...

Eli Lilly (LLY) stock dips as CVS Health (CVS) limits access to its weight loss drug Zepbound in favor of Novo Nordisk's (NVO ...

CVS Health raised its full-year profit forecast on Thursday following strong performance across its businesses, signaling ...

Q1 2025 Management View CEO David Joyner highlighted a strong start to 2025, reporting adjusted EPS of $2.25 and adjusted ...

Overall, CVS Health booked adjusted earnings of $2.25 per share as the company’s profit soared 60% to $1.78 billion in the year’s first quarter. Total revenue climbed 7% to $94.59 billion.

The Department of Justice filed a complaint against health insurers CVS Health-unit Aetna, Elevance Health and Humana, alleging they paid the kickbacks to insurance brokers eHealth, GoHealth and ...

CVS Health hiked its 2025 forecast above Wall Street’s expectations after improving Medicare benefits contributed to a better-than-expected first quarter CVS Health hiked its 2025 forecast above ...

Erik McGregor / LightRocket via Getty Images Shares of CVS Health surged as the company's first-quarter results easily topped estimates. The pharmacy and health insurance firm lifted its full-year ...